Posts
-
BLOG: The Two Year Moratorium With Provenge in the U.S.
Soon, Provenge will be available for terminally ill prostate cancer patients. This therapy should have been available to such patients two years ago. Published on: www.psa-rising.com The Unreachable Unavailability of Provenge *FDA’s mission statement: To...
-
BLOG: Proton therapy fights cancer
Richard Zuber wasn't surprised when his doctor told him he had prostate cancer. For years, prostate-specific antigen tests, which measure a protein in the blood produced by prostate tissue, showed elevated levels. A biopsy led...
